نتایج جستجو برای: پپتید pyy3 36
تعداد نتایج: 140459 فیلتر نتایج به سال:
due to an increase in obesity, the aim of the present study was to examine the effect of 12 weeks of endurance training on body weight, food intake, plasma acylated ghrelin and pyy3-36 in obese male rats. 16 male wistar rats were fed for 9 weeks with a high fat diet (derived from soybean oil) until they reached mean weight of 319±30 g. the rats were randomly divided into control group (n=8) and...
با توجه به روند رو به رشد اضافه وزن و چاقی، هدف از انجام این پژوهش، بررسی تأثیر 12 هفته تمرین استقامتی بر تغییرات وزن، غذای دریافتی، هورمون اشتهاآور آسیل گرلین و هورمون ضد اشتهای pyy3-36 در رت های نر چاق بود. 16 رت نر ویستار به مدت 9 هفته با غذای پرچرب (مشتق شده از روغن سویا) تغذیه شدند تا به میانگین وزنی g30 ±319 رسیدند. پس از همسان سازی، رت ها به صورت تصادفی در دو گروه 8 تایی کنترل و تمرین اس...
A number of studies have indicated that neuropeptide Y (NPY) is a central regulator of the gonadotropic axis, and the Y1 receptor was initially suggested to be implicated. As at least five different NPY receptor subtypes have now been characterized, the aim of the present study was to reinvestigate the pharmacological profile of the receptor(s) mediating the inhibitory action of NPY on LH secre...
Peptide YY (PYY)(3-36) has been shown to produce dramatic reductions in energy intake (EI), but no human data exist regarding energy expenditure (EE), glucose and fat metabolism. Nothing is known regarding PYY1-36. To compare effects of PYY(1-36) and PYY(3-36) on appetite, EI, EE, insulin, glucose and free fatty acids (FFA) concentrations, 12 lean and 12 obese males participated in a blinded, r...
Intraveneous (i.v.) PYY(3-36) infusions have been reported to reduce energy intake (EI) in humans, whereas few studies exist on effects of PYY(1-36). The aim of the present study was to examine effects of subcutaneous (sc) injections of PYY(1-36) and PYY(3-36) on appetite, ad libitum EI, plasma concentrations of PYY and free fatty acids (FFA) in obese males. Twenty-four males (BMI 27-40 kg/m(2)...
Obesity is a major public health issue worldwide. Understanding how the brain controls appetite offers promising inroads toward new therapies for obesity. Peptide YY (PYY) and glucagon-like peptide 1 (GLP-1) are coreleased postprandially and reduce appetite and inhibit food intake when administered to humans. However, the effects of GLP-1 and the ways in which PYY and GLP-1 act together to modu...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید